Badrinath Konety, MD
Urology · Minneapolis, MNNPI 1912937657
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $36,990 of the $45,396 with a category attached, or 81.5%. 8 manufacturers reported payments, led by Abbott at 34.9% of the total. Reporting peaked in 2024 at $23,416 and has fallen 88.9% since, to $2,600 in 2025. Among urology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $1681.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$16K
- Ferring Pharmaceuticals Inc.$7K
- Johnson & Johnson$7K
- E.r. Squibb & Sons, L.L.C.$6K
- Photocure Inc$5K
- Janssen Global Services, LLC$3K
- plus $3K from 2 others
Across 19 payments — averaging $9723.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$108K
- KARL Storz Endoscopy-america$39K
- E.r. Squibb & Sons, L.L.C.$38K
What the payments were for
- Consulting fees$36,99081%
- Speaking & faculty fees$7,50017%
- Food & beverage$9062%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 13 | $15,826 |
| Ferring Pharmaceuticals Inc. | 4 | $7,455 |
| Johnson & Johnson | 1 | $6,750 |
| E.r. Squibb & Sons, L.L.C. | 2 | $5,713 |
| Photocure Inc | 3 | $4,553 |
| Janssen Global Services, LLC | 1 | $2,600 |
| Verity Pharmaceuticals Inc. | 1 | $1,600 |
| Boston Scientific | 2 | $900 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPDIVO$4,613
- Cysview$4,500
- ADSTILADRIN$4,340
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$4,316
- AMPLATZER AMULET$2,438
- GENERAL - THERAPIES$450
- LithoVue$450
- NA$139
- ETERNA$108
How this compares
$45,396 in reported general payments places this provider in the 90th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 39 | $532 |
| Finasteride | 31 | $288 |
| Ciprofloxacin Hcl | 17 | $124 |
| Oxybutynin Chloride | 21 | $84 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $82 |
Paid to pharmacies, not to this prescriber.
Other urology in Minneapolis
- Ayman SoubraMinneapolis$204K
- Sean ElliottMinneapolis$163K
- Nissrine NakibMinneapolis$86K
- Travis PagliaraMinneapolis$53K
- Christopher WeightMinneapolis$16K
- James AndersonMinneapolis$5K
- Joseph AcquayeMinneapolis$4K
- Joseph PariserMinneapolis$4K
- David YangMankato$298K
- Steven BernsteinEdina$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.